144 related articles for article (PubMed ID: 6951500)
1. Thymic abnormalities: antigen or antibody? Response to thymectomy in myasthenia gravis.
Penn AS; Jaretzki A; Wolff M; Chang HW; Tennyson V
Ann N Y Acad Sci; 1981; 377():786-804. PubMed ID: 6951500
[TBL] [Abstract][Full Text] [Related]
2. Seronegative generalized myasthenia gravis: low frequency of thymic pathology.
Verma PK; Oger JJ
Neurology; 1992 Mar; 42(3 Pt 1):586-9. PubMed ID: 1296581
[TBL] [Abstract][Full Text] [Related]
3. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
Huang GZ; Lo YL
J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
[TBL] [Abstract][Full Text] [Related]
4. Assessment of pre and post-thymectomy myasthenia gravis.
Bokoliya SC; Patil SA
Neurol Res; 2019 Mar; 41(3):275-281. PubMed ID: 30574849
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
6. Management of myasthenia gravis by extended thymectomy with anterior mediastinal dissection.
Nussbaum MS; Rosenthal GJ; Samaha FJ; Grinvalsky HT; Quinlan JG; Schmerler M; Fischer JE
Surgery; 1992 Oct; 112(4):681-7; discussion 687-8. PubMed ID: 1411938
[TBL] [Abstract][Full Text] [Related]
7. "Maximal" thymectomy for myasthenia gravis. Results.
Jaretzki A; Penn AS; Younger DS; Wolff M; Olarte MR; Lovelace RE; Rowland LP
J Thorac Cardiovasc Surg; 1988 May; 95(5):747-57. PubMed ID: 3361927
[TBL] [Abstract][Full Text] [Related]
8. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 3. The effect of thymectomy.
Oosterhuis HJ; Limburg PC; Hummel-Tappel E; Van den Burg W; The TH
J Neurol Sci; 1985 Jul; 69(3):335-43. PubMed ID: 4031948
[TBL] [Abstract][Full Text] [Related]
9. Anti-acetylcholine receptor antibody titer with extended thymectomy in myasthenia gravis.
Kagotani K; Monden Y; Nakahara K; Fujii Y; Seike Y; Kitamura S; Masaoka A; Kawashima Y
J Thorac Cardiovasc Surg; 1985 Jul; 90(1):7-12. PubMed ID: 4010323
[TBL] [Abstract][Full Text] [Related]
10. Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis.
Ambrogi V; Mineo TC
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):601-6. PubMed ID: 22177829
[TBL] [Abstract][Full Text] [Related]
11. [Thymic lymphoid hyperplasia of myasthenia gravis patients: correlation with clinical features and efficacy of thymectomy].
Yoshitake T; Takahama T; Kanai F; Ohnishi K; Tamura K; Suzuki T; Kametani Y; Kataoka D; Nakata H; Itoyama S
Kyobu Geka; 1995 Jun; 48(6):447-51. PubMed ID: 7602854
[TBL] [Abstract][Full Text] [Related]
12. [Thymectomy in Chinese myasthenia gravis].
Chiu HC; Hsieh JM; Chen RC; Lin FY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):15-22. PubMed ID: 3595261
[TBL] [Abstract][Full Text] [Related]
13. The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer.
Okumura M; Ohta M; Takeuchi Y; Shiono H; Inoue M; Fukuhara K; Kadota Y; Miyoshi S; Fujii Y; Matsuda H
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1922-8. PubMed ID: 14688707
[TBL] [Abstract][Full Text] [Related]
14. A histologic reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy.
Alpert LI; Papatestas A; Kark A; Osserman RS; Osserman K
Arch Pathol; 1971 Jan; 91(1):55-61. PubMed ID: 4922629
[No Abstract] [Full Text] [Related]
15. Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study on 93 patients.
Nakahara K; Nakane S; Nakajima M; Yamashita S; Mori T; Ando Y
J Neuroimmunol; 2017 Apr; 305():182-185. PubMed ID: 28100409
[TBL] [Abstract][Full Text] [Related]
16. Effects of preoperative duration of symptoms on patients with myasthenia gravis.
Monden Y; Nakahara K; Kagotani K; Fujii Y; Nanjo S; Masaoka A; Kawashima Y
Ann Thorac Surg; 1984 Sep; 38(3):287-91. PubMed ID: 6476952
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.
Tsinzerling N; Lefvert AK; Matell G; Pirskanen-Matell R
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1109-12. PubMed ID: 17353257
[TBL] [Abstract][Full Text] [Related]
18. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
19. Treatment of myasthenia gravis: a comparison of the natural course and current therapies.
Seto M; Motomura M; Takeo G; Yoshimura T; Tsujihata M; Nagataki S
Tohoku J Exp Med; 1993 Jan; 169(1):77-86. PubMed ID: 8211972
[TBL] [Abstract][Full Text] [Related]
20. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Eur J Neurol; 2002 Jan; 9(1):55-61. PubMed ID: 11784377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]